Mitogen-activated protein kinase pathways

Current Opinion in Cell Biology

Volumn 9, Issue 2, 1997, Pages 180-186

  Robinson, Megan J ^a   Cobb, Melanie H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; STRESS;

EID: 0030898417     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(97)80061-0     Document Type: Article

References (87)

1. Cobb MH, Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 1995, 270:14843-14846.
2. Manser E, Leung T, Sailhuddin H, Tan L, Lim L: A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994, 367:40-46.
3. Pombo CM, Bonventre JV, Molnar A, Kyriakis J, Force T: Activation of a human Ste20-like kinase by oxidant stress defines a novel stress response pathway. EMBO J 1996, 15:4537-4546.
4. Taylor LK, Wang HCR, Erikson RL: Newly identified stress-responsive protein kinases, Krs-1 and Krs-2. Proc Natl Acad Sci USA 1996, 93:10099-10104.
5. Hirai S, Izawa M, Osada S, Spyrou G, Ohno S: Activation of the JNK pathway by distantly related protein kinases, MEKK and MUK. Oncogene 1996, 12:641-650.
6. Polverino A, Frost J, Yang P, Hutchison M, Neiman AM, Cobb MH, Marcus S: Activation of MAPK cascades by p21-activated protein kinases in cell-free extracts of Xenopus oocytes. J Biol Chem 1995, 270:26067-26070.
7. Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, Bokoch GM: Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J Biol Chem 1995, 270:23934-23936.
8. Rana A, Gallo K, Godowski P, Hirai S, Ohno S, Zon L, Kyriakis JM, Avruch J: The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1. J Biol Chem 1996, 271:19025-19028.
9. Wu X, Noh SJ, Zhou G, Dixon JE, Guan KL: Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells. J Biol Chem 1996, 271:3265-3271. Demonstrates selectivity of Raf family members for MEK1 versus MEK2.
10. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL: A divergence In the MAP kinase regulatory network defined by MEK kinase and Raf. Science 1993, 260:315-319.
11. Xu S, Robbins DJ, Christerson LB, English JM, Vanderbilt CA, Cobb MH: Cloning of rat MEK kinase 1 cDNA reveals an endogenous membrane-associated 195 kDa protein with a large regulatory domain. Proc Natl Acad Sci USA 1996, 93:5291-5295. The first paper to report the full-length cDNA sequence of MEKK1. Includes the identification of an amino-terminal putative regulatory sequence of MEKK1 and shows the particulate localization of the endogenous enzyme.
12. Johnson NL, Gardner AM, Diener KM, Lange-Carter CA, Gleavy J, Jarpe MB, Minden A, Karin M, Zon LI, Johnson GL: Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem 1996, 271:3229-3237. The first thorough study of the role of MEKK1 in cell death. Demonstrates a role for MEKK1 in apoptosis that is JNK/SAPK-independent.
13. Blank JL, Gerwisn P, Elliott EM, Sather S, Johnson GL: Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. J Biol Chem 1996, 271:5361-5368.
14. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K: Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 1995, 270:2008-2011. Defines a new class of MEKKs that is responsive to TGF-β and that activates stress-responsive MEKs.
15. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K: TAB1: an activator of the TAK1 MAPKKK in TGF-β signal transduction. Science 1996, 272:1179-1182.
16. Salmeron A, Ahmad TB, Carlile GW, Pappin D, Narsimhan RP, Ley SC: Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J 1996, 15:617-826.
17. Waskiewicz AJ, Cooper JA: Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast Curr Opin Cell Biol 1995, 7:798-805.
18. Zhou G, Qin Bao Z, Dixon JE: Components of a new human protein kinase signal transduction pathway. J Biol Chem 1995, 270:12665-12669.
19. Han J, Lee JD, Jiang Y, Li Z, Feng L, Ulevitch RJ: Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem 1996, 271:2886-2891.
20. Cheng M, Zhen E, Robinson MJ, Ebert D, Goldsmith E, Cobb MH: Characterization of a protein kinase that phosphorylates serine 189 of the mitogen-activated protein kinase homolog ERK3. J Biol Chem 1996, 271:12057-12062.
21. Robinson MJ, Cheng M, Khokhlatchev A, Ebert D, Ahn N, Guan KL, Stein B, Goldsmith E, Cobb MH: Contributions of the mitogen-activated protein (MAP) kinase backbone and phosphorylation loop to MEK specificity. J Biol Chem 1996, 271:29734-29740. The authors of this paper show that MAPK structure is more important than the sequence of the activation lip for MEK-MAPK specificity.
22. Brunet A, Pouyssegur J: Identification of MAP kinase domains by redirecting stress signals into growth factor responses. Science 1996, 272:1652-1655. Suggests that in vivo determinants of MEK-MAPK specificity are contributed by the amino-terminal domain of MAPK.
23. Catling AD, Schaeffer HJ, Reuter CWM, Reddy GR, Weber MJ: A proline-rich sequence unique to MEK1 and MEK2 is required for Raf binding and regulates MEK function. Mol Cell Biol 1995, 15:5214-5225. Suggests that a proline-rich insert region in MEK may couple it to Raf.
24. English JM, Vanderbilt CA, Xu S, Marcus S, Cobb MH: Isolation of MEK5 and differential expression of alternatively spliced forms. J Biol Chem 1995, 270:28897-28902.
25. Cheng M, Boulton TG, Cobb MH: ERK3 is a constitutively nuclear protein kinase. J Biol Chem 1996, 271:8951-8958.
26. Zervos AS, Faccio L, Gatto JP, Kyriakis JM, Brent R: Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc Natl Acad Sci USA 1995, 92:10531-10534.
27. Lechner C, Zahalka MA, Giot JF, Moller NPH, Ullrich A: ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA 1996, 93:4355-4359. Describes the cloning of the gene encoding the novel MAPK ERK6. ERK6 is ∼60% identical to p38 and may be involved in myoblast differentiation.
28. Mertens S, Craxton M, Goedert M: SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases. FEBS Lett 1996, 383:273-276.
29. Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Shengcai L, Han J: Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J Biol Chem 1996, 271:17920-17926. Reports the cloning of the p38β cDNA and the characterization of the protein p38β, which is ∼75% identical to p38. Reveals differences between p38 and p38β, such as the preferential activation of p38β by MEK6 and a substrate preference of p38β for ATF2 (activating transcription factor 2).
30. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ: Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996, 15:2760-2770.
31. Huang CYF, Ferrell JE: Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1996, 93:10078-10083. The authors of this paper analyze information flow in MAPK pathways, taking into account the relatively high cellular concentrations of ERK and MEK.
32. Wan Y, Kurosaki T, Huang XY: Tyrosine kinases in activation of the MAP kinase cascade by G-protein coupled receptors. Nature 1996, 380:541-544.
33. Kortenjann M, Shaw PE: Raf-1 kinase and ERK2 uncoupled from mitogenic signals in rat fibroblasts. Oncogene 1995, 11:2105-2112.
34. mapkk) in fibroblasts. J Cell Biol 1993, 122:1079-1088.
35. Chen RH, Sarnecki C, Blenis J: Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol 1992, 12:915-927.
36. Fukunda M, Gotoh I, Gotoh Y, Nishida E: Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J Biol Chem 1996, 271:20024-20028. An interesting paper that looks at the relatively unexplored area of kinase subcellular localization. The authors of this paper demonstrate that MEK contains a nuclear export signal that regulates its subcellular distribution. The authors also suggest a general mechanism for nuclear export.
37. Rutter GA, White MRH, Tavare JM: Involvement of MAP kinase in insulin signalling revealed by non-invasive imaging of luciferase gene expression in single living cells. Curr Biol 1995, 5:890-899. The authors used a novel technique to show the role of ERKs in insulin-dependent AP-1 (activating protein-1) transcription.
38. MAPK pathway. J Biol Chem 1996, 271:20608-20616. One of the first papers to provide a molecular connection between ERK activation and promotion of entry into the cell cycle.
39. Reszka AA, Seger R, Diltz CD, Krebs EG, Fischer EH: Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 1995, 92:8881-8885. The authors of this paper demonstrate a substantial cytoplasmic/cytoskeletal localization of ERKs in serum-stimulated cells.
40. Sakata N, Patel HR, Terada N, Aruffo A, Johnson GL, Gelfand EW: Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B celts. J Biol Chem 1995, 270:30823-30828. This paper shows that in B cells CD40 can activate the JNK pathway and rescue cells from apoptosis, whereas surface IgM cross-linking leads to ERK activation which can cause apoptosis.
41. Westwick JK, Weitzel C, Leffert HL, Brenner DA: Activation of Jun kinase is an early event in hepatic regeneration. J Clin Invest 1995, 95:803-810.
42. Hsueh YP, Lai MZ: c-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes. J Biol Chem 1995, 270:18094-18098.
43. Heidenreich KA, Kummer JL: Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J Biol Chem 1996, 271:9891-9894.
44. Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, Yoshida O: Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 1995, 55:4182-4187.
45. Xu X, Heidenreich O, Kitajima I, McGuire K, Li Q, Su B, Nerenberg M: Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oncogene 1996, 13:135-142. Shows that JNK is constitutively activated both in HTLV-1 -transformed human lymphocytes and in leukocytes isolated from adult T cell leukemia patients.
46. Franklin CC, Kraft AS: Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells. Oncogens 1995, 11:2365-2374.
47. Virdee K, Tolkovsky AM: Activation of p44 and p42 MAP kinases is not essential for the survival of rat sympathetic neurons. Eur J Neurosci 1995, 7:2159-2169.
48. Sano M, Kohno M, Iwanga M: The activation and nuclear translocation of extracellular signal-regulated kinases (ERK-1 and -2) appear not to be required for elongation of neurites in PC12D cells. Brain Res 1995, 688:213-218.
49. Creedon DJ, Johnson EM, Lawrence JC: Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J Biol Chem 1996, 271:20713-20718. Shows that the activation of ERK1/2 is not required for the effects of cAMP or nerve growth factor on the survival of primary sympathetic neurons.
50. English JD, Sweatt JD: Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J Biol Chem 1996, 271:24329-24332. Investigates the roles of ERK1 and ERK2 in the adult nervous system using hippocampal slices rather than PC12 cells. Finds that ERK2, but not ERK1, is activated in the CA1 area of the hippocampus after induction of long-term potentiation. Proposes that ERK2 is a regulator of synaptic plasticity in post-mitotic neurons.
51. 2-terminal kinases. Mol Cell Biol 1996, 16:648-656. Defines an ERK-independent pathway for PC12 cell differentiation; persistent activation of JNK is sufficient to induce such differentiation.
52. Kharbanda S, Pandey P, Ren R, Mayer B, Zon L, Kufe D: c-Abl activation regulates induction of the SEK1/stress-activated protein kinase pathway in the cellular response to 1-β-D-arabinofuranosylcytosine. J Biol Chem 1995, 270:30278-30281. Shows that c-Abl, which negatively regulates cell growth, activates the JNK/SAPK pathway in response to the DNA-damaging agent ara-C.
53. Pandey P, Raingeaud J, Kaneki M, Weichselbaum R, Davis RJ, Kufe D, Kharbanda S: Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and - independent mechanisms. J Biol Chem 1996, 271:23775-23779.
54. Wang X, Ron D: Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 1996, 272:1347-1349.
55. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ: FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J 1996, 15:4629-4642. A complete study of a mitogen-activated stress-response pathway. Examines FGF-mediated regulation of the opioid precursor proenkephalin in the human neuroblastoma cell line SK-N-MC. Finds that the FGF-activated pathway consists of p38, MAPKAP-2, and the transcription factor CREB. Suggests an interesting link between stress pathways and activation of opioid systems.
56. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331.
57. Liu Z, Hsu H, Goeddel DV, Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996, 87:565-576.
58. Gardner AM, Johnson GL: Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 1996, 271:14560-14566.
59. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y: JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994, 77:727-736.
60. Li W, Whaley CD, Mondino A, Mueller DL: Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science 1996, 271:1272-1276. Demonstrates reduced ERK and JNK/SAPK activities in murine anergic T cells.
61. Enslen H, Tokumitsu H, Stork PJS, Davis RJ, Soderling TR: Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade. Proc Natl Acad Sci USA 1996, 93:10803-10808.
62. Frodin M, Sekine N, Roche E, Filoux C, Prentki M, Wolheim CB, Van Obberghen E: Glucose, other secretagogues, and nerve growth factor stimulate mitogen-activated protein kinase in the insulin-secreting -cell line, INS-1. J Biol Chem 1995, 270:7882-7889.
63. Rossomondo AJ, Dent P, Sturgill TW, Marshak DR: Mitogen-activated protein kinase kinase 1 (MKK1) is negatively regulated by threonine phosphorylation. Mol Cell Biol 1994, 14:1594-1602.
64. Bokemeyer D, Sorokin A, Yan M, Ahn NG, Templeton DJ, Dunn MJ: Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts. J Biol Chem 1996, 271:639-642.
65. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H et al.: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995, 270:1491-1494. Shows that MAPK/ERK phosphorylates a site on the estrogen receptor that is required for full receptor activity.
66. 2) in thrombin-stimulated platelets. J Biol Chem 1996, 271:27723-27729.
67. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, Leslie CC, Krebs EG: Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem 1996, 271:505-511.
68. Ludwig S, Engel K, Hoffmeyer A, Sithanandam G, Neufeld B, Palm D, Gaestel M, Rapp UR: 3pk, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol 1996, 16:6687-6697.
69. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996. 15:1292-1300.
70. Yamada M, Komatsu N, Okada K, Kato T, Miyazaki H, Miura Y: Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line. Biochem Biophys Res Commun 1995, 217:230-237
71. Gines P, Li X, Zamarripa JL, Brown SES, Wieder ED, Nakamura T, Guzelian PS, Schrier RW, Heasley LE, Nemenoff RA: Tyrosine kinase growth factor receptors but not seven-membrane-spanning receptors or phorbol esters activate mitogen-activated protein kinase in rat hepatocytes. Hepatology 1995, 22:1296-1303.
72. Terada Y, Tomita K, Homma MK, Nonoguchi H, Yang T, Yamada T, Yuasa Y, Krebs EG, Marumo F: Sequential activation of MAP kinase cascade by angiotensin II in opossum kidney cells. Kidney Int 1995, 48:1801-1809.
73. Malarkey K, Chilvers ER, Lawson MF, Plevin R: Stimulation by endothelin-1 of mitogen-activated protein kinases and DNA synthesis in bovine tracheal smooth muscle cells. Br J Pharmacol-1995, 116:2267-2273.
74. Jones DA, Benjamin CW, Linseman DA: Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades. Mol Pharmacol 1995, 48:890-896.
75. Kurino M, Fukunaga K, Ushio Y, Miyamoto E: Activation of mitogen-activated protein kinase in cultured rat hippocampal neurons by stimulation of glutamate receptors. J Neurochem 1995, 65:1282-1289.
76. Bhat NR, Zhang P, Hogan EL: Thrombin activates mitogen-activated protein kinase in primary astrocyte cultures. J Cell Physiol 1995, 165:417-424.
77. Schorb W, Conrad KM, Singer HA, Dostal DE, Baker KM: Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J Mol Cell Cardiol 1995, 27:1151-1160.
78. lck. Tissue Antigens 1995, 46:155-162.
79. Ohmichi M, Koike K, Nohara A, Kanda Y, Sakamoto Y, Zhang ZX, Hirota K, Miyake A: Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. Endocrinology 1995, 136:2082-2087,
80. Hazlerigg DG, Thompson M, Hastings MH, Morgan PJ: Regulation of mitogen-activated protein kinase in the pars tubulis of the ovine pituitary: interactions between melatonin, insulin-like growth factor-1, and forskolin. Endocrinology 1996, 137:210-218.
81. lck and MAP kinase during IL-2-mediated lymphocyte proliferation. J Immunol 1995, 155:5623-5630.
82. Worby CA, Vega QC, Zhao Y, Chao HHJ, Seasholtz AF, Dixon JE: Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J Biol Chem 1996, 271:23619-23622.
83. Trejo J, Connolly AJ, Coughlin SR: The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. J Biol Chem 1996, 271:21536-21541.
84. 2 in vascular smooth muscle cells. Circ Res 1995, 77:29-36.
85. Oliver BL, Shaafi RI, Hajjar JJ: Transforming growth factor-α and epidermal growth factor activate mitogen-activated protein kinase and its substrates in intestinal epithelial cells. Soc Exp Biol Med 1995, 210:162-170.
86. Seko Y, Tobe K, Ueki K, Kadowaki T, Yazaki Y: Hypoxia and hypoxia/reoxygenation activate Raf-1, mitogen-activated protein kinase kinase, mitogen-activated protein kinases, and S6 kinase in cultured rat cardiac myocytes. Circ Res 1996, 78:82-90.
87. Wu J, Spiegel S, Sturgill TW: Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism. J Biol Chem 1995, 270:11484-11488.